Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9846
+0.0716 (7.84%)
Aug 4, 2026, 3:21 PM EDT - Market open

Outlook Therapeutics Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
0.331.41----
Revenue Growth
------
Gross Profit
-1.20.06----
Operating Income
-60.57-67.06-71.7-53.13-63.07-51.73
Net Income
-60.96-62.42-75.37-58.98-66.05-53.16
Earnings Per Share
-1.17-1.79-4.06-4.72-6.20-7.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
7.758.0814.9323.3917.414.48
Total Debt
27.1930.1929.7435.5610.9611.9
Net Cash (Debt)
-19.44-22.11-14.81-12.166.442.57
Net Cash Growth
----150.06%-77.26%
Net Cash Per Share
-0.34-0.64-0.80-0.970.610.34

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-47.05-51.83-68.79-42.97-56.67-54.25
Free Cash Flow
-47.05-51.83-68.79-42.97-56.67-54.25
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
-360.85%4.05%----
Operating Margin
-18182.80%-4744.25%----
Pretax Margin
-11842.73%-4526.01%----
Profit Margin
-18297.50%-4416.22%----
FCF Margin
-14121.80%-3666.65%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
499.6340.41----